Literature DB >> 1731441

Intravenous immunoglobulin in combination with other prophylactic and therapeutic measures.

U E Nydegger1.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1731441     DOI： 10.1046/j.1537-2995.1992.32192116438.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  3 in total

1.  Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.

Authors:  J D Lay; C J Tsao; J Y Chen; M E Kadin; I J Su
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 2.  Sepsis and septic shock. II. Treatment.

Authors:  J Mayer; R Hajek; J Vorlicek; M Tomiska
Journal:  Support Care Cancer       Date:  1995-03       Impact factor: 3.603

3.  Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan.

Authors:  I J Su; R L Chen; D T Lin; K S Lin; C C Chen
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.